4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-21-007637
EVP, General Counsel sold 54,659 shares at an average $63.99 ($3,497,902)
- EVP, General Counsel acquired 109,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Rivera Jose E · EVP, General Counsel
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +66,000 | $6.83 | $450,780 | 120,068 | D |
| 2021-02-01 | Sale : show line 2 in the form | −10,476 | $63.31 | $663,236 | 109,592 | D |
| 2021-02-01 | Sale : show line 3 in the form | −15,594 | $64.11 | $999,731 | 93,998 | D |
| 2021-02-01 | Sale : show line 4 in the form | −5,312 | $65.01 | $345,333 | 88,686 | D |
| 2021-02-01 | Exercise or conversion : show line 5 in the form | +33,000 | $13.88 | $458,040 | 121,686 | D |
| 2021-02-01 | Sale : show line 6 in the form | −6,617 | $63.34 | $419,121 | 115,069 | D |
| 2021-02-01 | Sale : show line 7 in the form | −8,366 | $64.16 | $536,763 | 106,703 | D |
| 2021-02-01 | Sale : show line 8 in the form | −2,827 | $65.05 | $183,896 | 103,876 | D |
| Open-market sales · 54,659 sh · avg $63.99 · $3,497,902 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 13 in the form Stock Option (right to buy) | −66,000 | 39,117 | D |
| 2021-02-01 | Exercise or conversion : show line 14 in the form Stock Option (right to buy) | −33,000 | 72,000 | D |
| 2021-02-01 | Exercise or conversion : show line 15 in the form Stock Option (right to buy) | −10,000 | 61,000 | D |
Loading xslF345X03/doc4.xml…